Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nihon Yakuhin Kogyo Co., Ltd. is a Japanese pharmaceutical company specializing in the development, manufacture, and distribution of ethical prescription drugs, with a primary focus on generic medications. Founded in 1947 and headquartered in Toyama, Japan, the company operates as a core subsidiary of Nichi-Iko Pharmaceutical Co., Ltd. Its extensive product portfolio includes a wide range of oral tablets, injections, and infusions targeting therapeutic areas such as cardiovascular, metabolic, and gastrointestinal health. The company maintains high-standard manufacturing facilities that comply with Good Manufacturing Practice (GMP) regulations to ensure a stable supply of high-quality medicines. Nihon Yakuhin Kogyo plays a vital role in the Japanese healthcare market by providing cost-effective therapeutic alternatives to brand-name drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nihon Yakuhin Kogyo.